Advances in HIV Research: Mechanisms, Transmission Routes, and Emerging Therapeutic Strategies

Yina Zhao

doi:10.54097/r5yv8q53

Authors

Yina Zhao

DOI:

https://doi.org/10.54097/r5yv8q53

Keywords:

HIV; AIDS; gene editing; CRISPR-Cas9; immunotherapy; transmission routes.

Abstract

Recently significant progress has been made towards the goal of achieving a cure for AIDS, but there is still a long way to go. This essay comprehensively reviews the latest advancements in HIV/AIDS research, emphasizing the virus's mechanisms of action, transmission routes, and emerging therapeutic strategies. HIV, a retrovirus that targets CD4+ T cells, continues to pose a significant global health challenge. The essay provides an overview of the HIV life cycle, highlighting the roles of viral envelope proteins and single-cell sequencing technology in understanding its intricate mechanisms, and discusses the progression of HIV from initial infection to AIDS, highlighting the ability of the virus to integrate into the host genome and evade the immune system. In addition, the paper analyzes HIV transmission routes, mainly sexual contact, blood contact, and mother-to-child transmission, and explores emerging treatment strategies, including gene-editing technologies such as CRISPR-Cas9, immunotherapy and cell therapies such as broadly neutralizing antibodies (bNAbs), HSCT, and vaccine development. While a cure remains elusive, these advancements offer hope for the future eradication of HIV/AIDS as a global health threat.

Downloads

Download data is not yet available.

References

[1] Assawinchaichote, W. , and S. Junhom. "Infection System with Dual Drug Dosages via an LMI Approach." (2011).

[2] Kanyalkar, Meena , et al. "Conformational study of fragments of envelope proteins (gp120: 254-274 and gp41: 519-541) of HIV-1 by NMR and MD simulations. " Journal of Peptide Science 10.6(2004):363–380.

[3] Deng L. Transition of two major conformational states of HIV-1 gp120. 2019. Yunnan University.

[4] Sun, Weiwei. , et al. "Phenotypic signatures of immune selection in HIV-1 reservoir cells." Nature (2023).

[5] Liying, Wang , M. Timothy R. , and Jane M., SimoniFlorence, NambiLylianne, NakabugoJoseph, KibuukaDorothy, ThomasIngrid T., KatzErika,FeutzKatherine K., ThomasNorma C., WareMonique A., WyattHerbert, KadamaAndrew, MujugiraRenee, Heffron. "Behavioral Modeling and its Association with PrEP and ART Use in Ugandan HIV-Serodifferent Couples." AIDS and behavior 28.5(2024):1719-1730.

[6] Huang, Z et al. “Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS.” Gene therapy vol. 24,7 (2017): 377-384.

[7] Newton Matthew D, et al. "DNA stretching induces Cas9 off-target activity.." Nature structural & molecular biology 26.3(2019):185-192.

[8] Jannifer Jasmin Thavarajah, Bo Langhoff Hønge, and Christian Morberg Wejse. "The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention.." Viruses 16.6(2024):911-911.

[9] Bryant, Adam , and S. Milliken . "Successful reduced-intensity conditioning allogeneic HSCT for HIV-related primary effusion lymphoma. " Biology of Blood and Marrow Transplantation 14. 5(2008):601-602.

[10] G. D. P. E. S. C. M. D. Souza, et al. "Epidemiological characterization of patients submitted to hematopoietic stem cell transplantation at a reference center in Curitiba, Paraná, Brazil, 2011-2015." ABCS Health Sciences 43(2018).

[11] Schiffner, T., Phung, I., Ray, R. et al. Vaccination induces broadly neutralizing antibody precursors to HIV gp41. Nat Immunol 25, 1073–1082 (2024).

[12] Chaudhary Namit, Weissman Drew, and Whitehead Kathryn A. "mRNA vaccines for infectious diseases: principles, delivery and clinical translation.." Nature reviews. Drug discovery 20.11(2021):817-838.